250 likes | 321 Views
Higher Level Practitioner Development: A Way Forward in the South East. BOPA Symposium 2007 Michael Powell Lead Pharmacist Mount Vernon Cancer Network. Aims. To outline the function of the Joint Programme Board
E N D
Higher Level Practitioner Development: A Way Forward in the South East BOPA Symposium 2007 Michael Powell Lead Pharmacist Mount Vernon Cancer Network
Aims • To outline the function of the Joint Programme Board • To describe the pharmacy practitioner development strategy as it relates to higher level practice • To describe current and likely future developments in higher level practice in the South East. How might these be relevant to oncology pharmacy practice?
Why reform post-registration education? • No systematic provision of post grad education for pharmacy practitioners. • Level of current provision evolved in somewhat haphazard way from the need for a level of clinical pharmacist skills and knowledge not catered for by undergrad/pre-reg curricula
Why reform post-registration education? • Foster Report (July 2006): • Re-emphasises the need for competence linked with performance assessment • Emphasises the need for re-validation: • Ongoing evaluation of an individual’s fitness to practice • Must be both formative and summative Department of Health. The regulation of the non-medical healthcare professions. A review by the Department of Health. July 2006.
The Joint Programme Board (JPB): Membership and Function
What is the JPB? Collaboration NHS Specialist Services Specialist groups Senior Managers Service Perspective Educational Quality Academia (SOPs) Brighton KCL Medway Portsmouth London UEA
Key JPB Responsibilities • Develop uniform & coherent curricula for general and advanced practice • Develop tutor training courses to support work-based learning • Design reliable, fair & appropriate assessments • Undertake the accreditation of training centres • Build systems for on-going QA of E&T systems • Assign academic credits to programmes as appropriate • Issue statements of completion of training at general & advanced levels.
To Date – Generalist Training Band 6 (3 years) • PG Diploma in General Pharmacy Practice (MI, Technical, Patient & Clinical Services plus “tasters” of specialist areas) • Validated by 5 of the JPB HEI’s • Statement of completion of general training • Currently 200 practitioners/students across the south-east
JPB as a supportive infrastructure The NHS SPMs, Training Centres, Specialist Pharmacy Services HEIs Post-Registration Pharmacy Joint Programmes Board Training Centres (Gen + Specialist) Directors Pharmacy Education (Trust/Pan-Trust Roles) The NHS Pharmacy SIGs ?
Developing the infrastructure – key principles • Work-based learning • Resources practice tutors • Assesses competence and performance • Systems for dealing with poor performance • Standardises approaches across specialties
Training infrastructure support Higher Level Practice System PG enabling programmes Research Degree General Diploma Masters Adv Practice Higher Level Development Phase 2 Higher Level Development Phase 1 General Level Development Phase Consultant Practitioner Undergraduate & Pre-registration Phases Advanced Practitioner General Level Practitioner General Level Framework Higher Level Framework: Advanced & Consultant
JPB (Regional e.g. South East England) Training Centres •Single Trusts or collaboratives – across health sectors •Accredited to deliver training at Generalist, Higher Level or both •Internal QA systems •Manage tutee experiences
Higher Level Practice The Career Pathway
Practitioner Development Strategy • Imperative to recognise formally that there are different levels of practice: • complex & diverse nature of pharmacist roles • Clinical governance • Impact of AfC D Webb et al. Hosp Pharm Mar 2004; 11: 104-109
Practitioner Development Strategy • Different levels of practice must capture: • Clinical pharmacy specialisation (e.g. oncology) • Expertise in other disciplines (e.g. MI, tech services) • Should be sector independent: • Should encompass pharmacy practitioners within 1°/2° care and community pharmacy D Webb et al. Hosp Pharm Mar 2004; 11: 104-109
JPB & Higher Level Practice • Focus now on developing strategy for higher level practitioner development • Scoping meetings held in London in January and May 2007 • Key themes: • Consistency • Overcoming silo mentality • Identifying barriers • Overcoming barriers • System of representation • Collaborations with HEIs • Time frames • Duality of award • Titles
Practitioner development strategy: Alignment with AfC Band 8 b-d (3 yrs) Band 7 – 8a (3-5yrs) Higher Level Development Phase 2 Band 6 (3yrs) Higher Level Development Phase 1 General Level Development Phase Consultant Practitioner Undergraduate & Pre-registration Phases Advanced Practitioner General Level Practitioner General Level Framework Higher Level Framework: Advanced & Consultant
Higher Level Practice Using the ACLF as the backbone
Advanced & Consultant Level Framework (ACLF) • 34 competencies in 6 clusters: • Expert professional practice (EPP) • Building working relationships (BR) • Leadership (L) • Management (M) • Education, training & development (ETD) • Research & evaluation (RE) • Each competency has 3 levels of attainment: Foundation, excellence & mastery • In England, describes the competency profiles expected of applicants for consultant pharmacist posts
Consultant profile EPP, BR and L at Mastery M, ETD and RE at Excellence Advanced profile 5 clusters at Excellence RE at Foundation PhwSI profile 4 clusters at Excellence 2 clusters ETD, RE optional Competency Profiles
JPB – some key facts • JPB does not influence Specialist Group alliances or relationships • JPB is a system for discharging the curriculum – which belongs to the specialist group • JPB is an inclusive system – engages all SGs and all HEIs – promotes local relationships rather than aligning with one HEI. • Research commitment to final aspect (8b-d) requires local HEI engagement • Encourages all SGs to collaborate to standardise the output across specialities • JPBs must maintain a geographical relationship which builds on existing and historical networks.
Accreditation • Clear recognition that JPB should work with specialist groups such as BOPA to: • Design the curricula for general & advanced level practice • Design appropriate assessment methods to meet the learning outcomes associated with general & advanced practice • Assessment of portfolio of evidence • Viva
Latest Developments with the JPB Dr Catherine Duggan Associate Director of Clinical Pharmacy for Evaluation and Development &Senior Clinical LecturerLondon, Eastern and South East NHS and School of Pharmacy,University of London
Further reading • Key literature on practitioner development: • Davies et al. Hosp Pharm Jan 04; 11: 2 • Webb et al. Hosp Pharm Mar 04; 11: 104-109 • Bates et al. Pharm J Mar 04; 272: 283 • Websites for further info: • JPB: www.postgraduatepharmacy.org • CoDEG: www.codeg.org